NCT05284019: Real World Effectiveness of Eptinezumab in Participants With Migraine
- State
- Stopped early
- Phase
- Phase 4
- People
- 32 taking part
- Started
- 4 Mar 2022
- Primary completion
- 17 Feb 2023
- Arms
- Onabotulinumtoxin-A
- Results
- Posted on the registry
- 4 Mar 2022: Trial started
- 17 Mar 2022: Trial registered
- 14 Apr 2023: Trial terminated
- 29 May 2024: Trial results posted